Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3099175rdf:typepubmed:Citationlld:pubmed
pubmed-article:3099175lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C0021031lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C0002721lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:3099175lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:3099175pubmed:issue10lld:pubmed
pubmed-article:3099175pubmed:dateCreated1987-1-23lld:pubmed
pubmed-article:3099175pubmed:abstractTextIn order to clarify the mechanism of interaction of serum amyloid P component (SAP) with complement, the interaction of SAP with C1q and with IgG was studied. It is known that SAP binds Sepharose in the presence of calcium. When purified 125I-C1q was incubated with SAP prior to Sepharose affinity chromatography, 125I-C1q was retained. However, in the absence of SAP, the 125I-C1q was not retained. To further examine the interaction of SAP with C1q, isolated SAP was incubated at varying ratios with C1q in the presence of 1.5 mM Ca2+. These mixtures were subsequently examined via crossed immunoelectrophoresis against goat anti-SAP. A change in the electrophoretic behavior of SAP was observed in the presence of C1q. In other studies, it was observed that SAP might interact with the collagen-like stem of C1q. In these latter studies, 125I-SAP was incubated with pepsin digests of C1q in a microtitre solid-phase binding assay. In addition, a microtitre solid-phase binding assay was utilized in order to investigate the possible binding of isolated 125I-SAP with IgG. Interestingly in the presence of Ca2+, human IgG and Fab gamma, but not Fc gamma, were found to bind 125I-SAP.lld:pubmed
pubmed-article:3099175pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:languageenglld:pubmed
pubmed-article:3099175pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:citationSubsetIMlld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3099175pubmed:statusMEDLINElld:pubmed
pubmed-article:3099175pubmed:monthOctlld:pubmed
pubmed-article:3099175pubmed:issn0161-5890lld:pubmed
pubmed-article:3099175pubmed:authorpubmed-author:BoackleR JRJlld:pubmed
pubmed-article:3099175pubmed:authorpubmed-author:BristowC LCLlld:pubmed
pubmed-article:3099175pubmed:issnTypePrintlld:pubmed
pubmed-article:3099175pubmed:volume23lld:pubmed
pubmed-article:3099175pubmed:ownerNLMlld:pubmed
pubmed-article:3099175pubmed:authorsCompleteYlld:pubmed
pubmed-article:3099175pubmed:pagination1045-52lld:pubmed
pubmed-article:3099175pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:meshHeadingpubmed-meshheading:3099175-...lld:pubmed
pubmed-article:3099175pubmed:year1986lld:pubmed
pubmed-article:3099175pubmed:articleTitleEvidence for the binding of human serum amyloid P component to Clq and Fab gamma.lld:pubmed
pubmed-article:3099175pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3099175pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099175lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099175lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099175lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3099175lld:pubmed